The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening.
Value Health
; 17(7): A559, 2014 Nov.
Article
en En
| MEDLINE
| ID: mdl-27201843
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Prevalence_studies
/
Risk_factors_studies
/
Screening_studies
Idioma:
En
Año:
2014
Tipo del documento:
Article